Abivax will be hosting an Industry Symposium at the UEG Week Virtual 2021 on Monday, October 4, 2021 at 1:00-2:00pm CEST (7:00-8:00am EST) on “ABX464, a novel anti-inflammatory drug-candidate for the treatment of ulcerative colitis”. Presentations on the continued need for novel drugs in IBD and the potential of ABX464 to address them will be given by the internationally renowned KOLs Prof. Bruce Sands, M.D., M.S. and Prof. William Sandborn, M.D. In addition, Didier Scherrer, Ph.D., Vice-President R&D at Abivax, will talk about the differentiation factors of ABX464’s novel and unique mechanism of action.